Si-Bone (SIBN) Capital Expenditures Growth (1y) (2018 - 2026)
Si-Bone (SIBN) Capital Expenditures Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 27.22% |
| 10 | Si-Bone | 696.98 Mn | 556.86 Mn | 41.94 Mn | -74.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.66% |
| Dec 31, 2025 | 98.72% |
| Sep 30, 2025 | -106.11% |
| Jun 30, 2025 | -33.71% |
| Mar 31, 2025 | -0.48% |
| Dec 31, 2024 | -2,106.04% |
| Sep 30, 2024 | 234.12% |
| Jun 30, 2024 | -129.07% |
| Mar 31, 2024 | -19.27% |
| Dec 31, 2023 | 105.66% |
| Sep 30, 2023 | -244.82% |
| Jun 30, 2023 | 35.63% |
| Mar 31, 2023 | 13.41% |
| Dec 31, 2022 | -19,334.29% |
| Sep 30, 2022 | 196.10% |
| Jun 30, 2022 | -9.66% |
| Mar 31, 2022 | 15.08% |
| Dec 31, 2021 | -95.72% |
| Sep 30, 2021 | -332.46% |
| Jun 30, 2021 | 2,281.72% |